Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure
- PMID: 12642504
- DOI: 10.1161/01.HYP.0000062465.60601.CC
Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure
Abstract
The present study was undertaken to elucidate the G-protein and mitogen-activated kinase (MAP kinase) coupled signaling profile in a genetic model of hypertension and congestive heart failure (CHF) that mimics similar disease in humans. At the receptor level, Ang II type 1 receptor (AT1R) increased in left ventricular hypertrophy (LVH) and reverted to normal in CHF, whereas there was a downregulation of the Ang II type 2 receptor (AT2R) in CHF. At the transducer level, Galphaq and Galpha12 protein levels were unchanged during LVH but decreased significantly in CHF. In contrast, Gbeta and Galpha13 protein content were markedly upregulated in CHF. Furthermore, using phospho-specific antibodies in Western blots and in vitro kinase assays, we found at the effector level an upregulation of the small G-protein Rac1 activity during LVH but a decrease during CHF. In parallel, small G-protein Rho activity was significantly increased during LVH but was unchanged in failure. We found at the downstream level that MAP kinase isoforms extracellular signal regulated-kinase (ERK1/2), big mitogen-activated kinase (BMK1/ERK5), C-jun N-terminal-activated kinase (JNKs/SAPKs), and stress-activated kinase (p38) bioactivities were increased during LVH. During CHF, ERK1/2 and JNK1/2 kinase activities were decreased, whereas BMK1/ERK5 kinase activity reverted to normal values. In conclusion, this study demonstrates, for the first time, multistep alterations of G-protein and MAP kinase signaling pathways in LVH and progression to failure in a genetic model of hypertension and failure.
Similar articles
-
Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.J Mol Cell Cardiol. 2001 Apr;33(4):733-44. doi: 10.1006/jmcc.2001.1341. J Mol Cell Cardiol. 2001. PMID: 11273726
-
Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.J Mol Med (Berl). 2001 Sep;79(9):510-21. doi: 10.1007/s001090100243. J Mol Med (Berl). 2001. PMID: 11692164
-
Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.Hypertension. 2016 Jan;67(1):86-98. doi: 10.1161/HYPERTENSIONAHA.115.05957. Epub 2015 Nov 16. Hypertension. 2016. PMID: 26573707 Review.
-
Src and multiple MAP kinase activation in cardiac hypertrophy and congestive heart failure under chronic pressure-overload: comparison with acute mechanical stretch.J Mol Cell Cardiol. 2001 Sep;33(9):1637-48. doi: 10.1006/jmcc.2001.1427. J Mol Cell Cardiol. 2001. PMID: 11549343
-
Cardiac sarcomeric function, small G-protein signaling, and heart failure.Panminerva Med. 2005 Sep;47(3):133-42. Panminerva Med. 2005. PMID: 16462722 Review.
Cited by
-
Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.Circ Res. 2010 Mar 19;106(5):961-70. doi: 10.1161/CIRCRESAHA.109.209320. Epub 2010 Jan 14. Circ Res. 2010. PMID: 20075332 Free PMC article.
-
Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.Physiol Rev. 2010 Oct;90(4):1507-46. doi: 10.1152/physrev.00054.2009. Physiol Rev. 2010. PMID: 20959622 Free PMC article. Review.
-
LOX-1 and angiotensin receptors, and their interplay.Cardiovasc Drugs Ther. 2011 Oct;25(5):401-17. doi: 10.1007/s10557-011-6331-7. Cardiovasc Drugs Ther. 2011. PMID: 21861069 Free PMC article. Review.
-
HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway.Int J Mol Med. 2019 Sep;44(3):885-892. doi: 10.3892/ijmm.2019.4276. Epub 2019 Jul 16. Int J Mol Med. 2019. PMID: 31524228 Free PMC article.
-
Deletion of Shp2 tyrosine phosphatase in muscle leads to dilated cardiomyopathy, insulin resistance, and premature death.Mol Cell Biol. 2009 Jan;29(2):378-88. doi: 10.1128/MCB.01661-08. Epub 2008 Nov 10. Mol Cell Biol. 2009. PMID: 19001090 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous